Ryuya Yamanaka

Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein ɛ-deficient mice

Ryuya Yamanaka, Carrolee Barlow, Julie Lekstrom-Himes et al. · Proceedings of the National Academy of Sciences · 1997 · 383 citations · Full text

Lymphocyte Development, Immunology, Immune Regulation +19

Clinical Evaluation of Dendritic Cell Vaccination for Patients with Recurrent Glioma: Results of a Clinical Phase I/II Trial

Ryuya Yamanaka, Junpei Homma, Naoki Yajima et al. · Clinical Cancer Research · 2005 · 318 citations · Full text

Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial

Ryuya Yamanaka, Takashi Abe, Naoki Yajima et al. · British Journal of Cancer · 2003 · 262 citations · Full text

CCAAT/enhancer binding protein ɛ is preferentially up-regulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing

Ryuya Yamanaka, Gun‐Do Kim, Hanna S. Radomska et al. · Proceedings of the National Academy of Sciences · 1997 · 182 citations · Full text

EphA4 promotes cell proliferation and migration through a novel EphA4-FGFR1 signaling pathway in the human glioma U251 cell line

Junya Fukai, Hideyuki Yokote, Ryuya Yamanaka et al. · Molecular Cancer Therapeutics · 2008 · 156 citations